check_circleStudy Completed

Pneumonia

Bayer Identifier:

15465

ClinicalTrials.gov Identifier:

NCT01416506

EudraCT Number:

Not Available

EU CT Number:

Not Available
Community-Acquired Pneumonia (CAP) surveillance

Trial purpose

Prospective, non-interventional, multi-center study. 7 investigative centers will involved in China. Around 560 CAP outpatients or inpatients will be screened until 56 M. pneumoniae isolates collected.

Key Participants Requirements

Sex

Both

Age

18 - N/A
  • - Chinese adult (male or female) ≥18 years old
    - Outpatients or inpatients who suffer from CAP

  • -

Trial summary

Enrollment Goal
560
Trial Dates
September 2010 - January 2013
Phase
N/A
Could I Receive a placebo
No
Products
No Drug
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Many Locations, China

Primary Outcome

  • In vitro Minimal Inhibitory Concentration Detection
    date_rangeTime Frame:
    Up to 27 months
    enhanced_encryption
    Safety Issue:
    No

Secondary Outcome

  • In vitro Gene Mutation Detection
    date_rangeTime Frame:
    Up to 15 months
    enhanced_encryption
    Safety Issue:
    No

Trial design

Community-Acquired Pneumonia (CAP) Mycoplasma Surveillance
Trial Type
Observational
Intervention Type
Other
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.